Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TMS for Cognitive Decline in Aging and Preclinical AD — Stella

Home/Prodromal Alzheimer's Disease/TMS for Cognitive Decline in Aging and Preclinical AD

View on ClinicalTrials.gov

Recruiting

Back to Prodromal Alzheimer's Disease trials

TMS for Cognitive Decline in Aging and Preclinical AD

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Massachusetts General Hospital, Boston, Massachusetts

Key details

Sponsor

Massachusetts General Hospital

Enrollment target

~80 participants

Started

April 2025

Primary completion

August 2029

Age range

40 Years – 99 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.